AMPH logo

Amphastar Pharmaceuticals (AMPH) Short Term Debt

Annual Short Term Debt

$4.34 M
-$1.71 M-28.22%

31 December 2023

AMPH Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$4.46 M
+$216.00 K+5.09%

30 September 2024

AMPH Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMPH Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.2%+7.4%
3 y3 years-72.2%-12.8%
5 y5 years-76.2%-55.6%

AMPH Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-72.2%at low-72.2%+7.4%
5 y5 years-76.2%at low-72.2%+7.4%
alltimeall time-80.4%at low-86.0%+7.4%

Amphastar Pharmaceuticals Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$4.46 M(+5.1%)
June 2024
-
$4.25 M(-2.9%)
Mar 2024
-
$4.37 M(+0.6%)
Dec 2023
$4.34 M(-28.2%)
$4.34 M(+4.6%)
Sept 2023
-
$4.15 M(-74.1%)
June 2023
-
$16.05 M(+211.2%)
Mar 2023
-
$5.16 M(-14.7%)
Dec 2022
$6.05 M(+16.7%)
$6.05 M(+24.4%)
Sept 2022
-
$4.86 M(-9.5%)
June 2022
-
$5.37 M(-1.2%)
Mar 2022
-
$5.44 M(+4.9%)
Dec 2021
$5.18 M(-66.8%)
$5.18 M(+1.3%)
Sept 2021
-
$5.12 M(-54.8%)
June 2021
-
$11.31 M(-28.7%)
Mar 2021
-
$15.88 M(+1.6%)
Dec 2020
$15.62 M(+43.1%)
$15.62 M(-1.2%)
Sept 2020
-
$15.81 M(+1.6%)
June 2020
-
$15.56 M(+4.1%)
Mar 2020
-
$14.94 M(+36.9%)
Dec 2019
$10.92 M
$10.92 M(+8.5%)
Sept 2019
-
$10.06 M(+3.9%)
June 2019
-
$9.68 M(-52.0%)
DateAnnualQuarterly
Mar 2019
-
$20.15 M(+10.5%)
Dec 2018
$18.23 M(+188.8%)
$18.23 M(-2.0%)
Sept 2018
-
$18.59 M(-1.6%)
June 2018
-
$18.89 M(+211.7%)
Mar 2018
-
$6.06 M(-4.0%)
Dec 2017
$6.31 M(+17.6%)
$6.31 M(+1.6%)
Sept 2017
-
$6.21 M(+0.1%)
June 2017
-
$6.21 M(+17.9%)
Mar 2017
-
$5.26 M(-1.9%)
Dec 2016
$5.37 M(-50.9%)
$5.37 M(-37.2%)
Sept 2016
-
$8.54 M(-21.7%)
June 2016
-
$10.90 M(-2.4%)
Mar 2016
-
$11.18 M(+2.2%)
Dec 2015
$10.93 M(+44.0%)
$10.93 M(-25.9%)
Sept 2015
-
$14.76 M(+16.9%)
June 2015
-
$12.63 M(+0.8%)
Mar 2015
-
$12.53 M(+65.0%)
Dec 2014
$7.59 M(-65.6%)
$7.59 M(-24.6%)
Sept 2014
-
$10.08 M(-5.5%)
June 2014
-
$10.66 M(-66.6%)
Mar 2014
-
$31.89 M(+44.3%)
Dec 2013
$22.10 M(+0.2%)
$22.10 M
Dec 2012
$22.05 M
-

FAQ

  • What is Amphastar Pharmaceuticals annual short term debt?
  • What is the all time high annual short term debt for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual short term debt year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly short term debt?
  • What is the all time high quarterly short term debt for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly short term debt year-on-year change?

What is Amphastar Pharmaceuticals annual short term debt?

The current annual short term debt of AMPH is $4.34 M

What is the all time high annual short term debt for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual short term debt is $22.10 M

What is Amphastar Pharmaceuticals annual short term debt year-on-year change?

Over the past year, AMPH annual short term debt has changed by -$1.71 M (-28.22%)

What is Amphastar Pharmaceuticals quarterly short term debt?

The current quarterly short term debt of AMPH is $4.46 M

What is the all time high quarterly short term debt for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly short term debt is $31.89 M

What is Amphastar Pharmaceuticals quarterly short term debt year-on-year change?

Over the past year, AMPH quarterly short term debt has changed by +$309.00 K (+7.44%)